Yves Poulin
Quebec, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 91 publications
French translation and adaptation of the KDIGO nomenclature for kidney function and disease
Journal: Nephrologie & therapeutique
Published: February 07, 2025
Correction to: Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel.
Journal: Dermatology and therapy
Published: July 06, 2023
Phase 2 Trial of Topical Thykamine in Adults With Mild to Moderate Atopic Dermatitis.
Journal: Journal of drugs in dermatology : JDD
Published: October 11, 2022
Use of Systemic Therapies for Treatment of Psoriasis in People Living with Controlled HIV: Inference-Based Guidance from a Multidisciplinary Expert Panel.
Journal: Dermatology and therapy
Published: March 04, 2022
Treatment Guidelines for Atopic Dermatitis Since the Approval of Dupilumab: A Systematic Review and Quality Appraisal Using AGREE-II.
Journal: Frontiers in medicine
Published: November 24, 2021
Practical and Relevant Guidelines for the Management of Psoriasis: An Inference-Based Methodology.
Journal: Dermatology and therapy
Published: September 30, 2021
A Review of the Efficacy and Safety for Biologic Agents Targeting IL-23 in Treating Psoriasis With the Focus on Tildrakizumab.
Journal: Frontiers in medicine
Published: April 29, 2021
Psoriasis Prevalence and Severity by Expert Elicitation.
Journal: Dermatology and therapy
Published: February 04, 2021
Tralokinumab for moderate-to-severe atopic dermatitis: results from two 52-week, randomized, double-blind, multicentre, placebo-controlled phase III trials (ECZTRA 1 and ECZTRA 2).
Journal: The British journal of dermatology
Published: September 25, 2020
Position statement for a pragmatic approach to immunotherapeutics in patients with inflammatory skin diseases during the coronavirus disease 2019 pandemic and beyond.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: September 07, 2020
Long-term efficacy of certolizumab pegol for the treatment of plaque psoriasis: 3-year results from two randomized phase III trials (CIMPASI-1 and CIMPASI-2).
Journal: The British journal of dermatology
Published: July 07, 2020
Real-World Experience With Apremilast in the Treatment of Adults With Moderate to Severe Plaque Psoriasis in Québec: A Claims-Based Analysis of Drug Utilization and Healthcare Resource Utilization.
Journal: Journal of cutaneous medicine and surgery
Published: June 30, 2020
Last Updated: 09/26/2026